Clinical trial
Characterizing Absorption Kinetics of Oral Antibiotics in Young Infants to Enhance Precision Dosing
NCT07815613 is registered in ClinicalTrials.gov with University of Colorado, Denver as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Characterizing Absorption Kinetics of Oral Antibiotics in Young Infants to Enhance Precision Dosing
- Lead sponsor
- University of Colorado, Denver
- Phase
- Phase 4
- Overall status
- Not yet recruiting
- Start date
- January 1, 2027
- Completion date
- December 31, 2030
- Enrollment
- 40 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
infant and young children, linezolid, linezolid pharmacokinetics in young infants, pharmacokinetic analysis